CalciMedica is trading 6.17% down at $1.52 in pre-market on October 1, amid a September 30 filing allowing up to $25 million in common-stock sales; whether it prompted the decline is unconfirmed. - The filing covers sales through its existing at-the-market offering agreement. - The shares fell from $1.87 on September 22 to $1.62 at the September 30 close. - No separate October 1 company announcement surfaced; broad market indicators were mixed, not a clear explanation.